. Altering CB 1 function by either increasing endocannabinoid production or removing its tonic activity allowed us to demonstrate that CB 1 controls GABA release by inhibiting Ca 2ϩ entry into presynaptic axon terminals via N-type (Cav2.2) Ca 2ϩ channels. These results provide evidence for modulation of intrabouton Ca 2ϩ influx into GABAergic axon terminals by CB 1 , leading to the effective suppression of synaptic inhibition.
Introduction
G-protein-coupled receptors (GPCRs), one of the largest protein families coded in the genome (Bjarnadó ttir et al., 2006) , are key regulators of several neuronal functions, including the control of synaptic communication (Hille, 1992) . GPCR-dependent regulation of synaptic transmission at axon terminals has been shown to involve the opening of K ϩ channels, inhibition of Ca 2ϩ channels, blocking vesicle fusion, or the combination of these processes (Miller, 1998; de Jong and Verhage, 2009) .
CB 1 , one of the most abundant GPCRs in the CNS, is the main receptor of endocannabinoids and the psychoactive ingredient of marihuana (Zimmer et al., 1999; Wilson and Nicoll, 2001 ). This presynaptic receptor potently affects circuit operation by reducing neurotransmitter release both at excitatory and inhibitory synapses (Kreitzer and Regehr, 2001; Wilson et al., 2001; Brown et al., 2004; Katona and Freund, 2008; Kano et al., 2009) . It has been demonstrated that glutamate release is effectively reduced by CB 1 activation in parallel with the suppression of Ca 2ϩ influx into cerebellar parallel fiber axon terminals (Kreitzer and Regehr, 2001; Zhang and Linden, 2009 ). However, the precise mechanism of action is still controversial, because the reduction of Ca 2ϩ entry into boutons could be the consequence of either a direct decrease of voltage-gated Ca 2ϩ channel function (Brown et al., 2004) or an indirect effect through the opening of presynaptic K ϩ channels (Daniel and Crepel, 2001; Daniel et al., 2004 ). In contrast, the mechanism underlying the reduction of inhibitory synaptic transmission upon CB 1 activation at single-bouton level is still an open question. In this study, we combined electrophysiological recordings with two-photon imaging to address this issue.
Materials and Methods
Slice preparation. CD1 or transgenic mice expressing DsRed fluorescent protein under the control of the cholecystokinin promoter of either sex (postnatal days 16 -25) were used (CCK-BAC/DsRedT3 mouse line; Máté et al., 2013) . Horizontal hippocampal slices at 250 m thickness were cut. Animals were anesthetized with isoflurane and decapitated in accordance with the Hungarian Act of Animal Care and Experimentation (1998 , XXVIII, Section 243/1998 , and with the ethical guidelines of the Institute of Experimental Medicine Protection of Research Subjects Committee. The brains were quickly removed and placed into an ice-cold solution containing the following (in mM): sucrose 204.5, KCl 2.5, NaHCO 3 26, CaCl 2 0.5, MgCl 2 5, NaH 2 PO 4 1.25, glucose 10, saturated with 95% O 2 and 5% CO 2 , pH 7.2-7.4. Hippocampal slices were prepared using a Leica vibratome (Leica VT1200S; Leica Microsystems), then transferred into an interface-type holding chamber filled with 36°C aCSF containing the following (in mM): NaCl 126, KCl 2.5, NaHCO 3 26, CaCl 2 2, MgCl 2 2, NaH 2 PO 4 1.25, glucose 10, saturated with 95% O 2 and 5% CO 2 , pH 7.2-7.4. Slices were kept up to 6 h in the holding chamber before recordings. The same solutions were used during electrophysiological and two-photon imaging experiments.
Electrophysiological recordings. Slices were transferred to a submerged recording chamber. The flow rate was 2-3 ml/min. Experiments were performed at room temperature under visual guidance. For electrophysiological recordings, an Olympus microscope (BX61WI) was used equipped with a monochromator. DsRed in cells was excited at 488 nm wavelength, and the resulting fluorescence was detected with a CCD camera (TILL Photonics). Whole-cell patch-clamp recordings were made using a Multiclamp 700B amplifier (Molecular Devices), traces were filtered at 3 kHz, digitized at 10 kHz with a PCI-6024E board (National Instruments), recorded with an in-house data acquisition and stimulation software, and off-line analyzed using EVAN software (courtesy of Istvan Mody, Department of Neurology, UCLA). Patch pipettes were pulled (Zeitz Universal Puller, Zeitz-Instrumente Vertriebs) from thin-walled borosilicate glass capillaries with an inner filament (1.5 mm outer diameter, 1.17 mm inner diameter; Harvard Apparatus). Pipette resistance was 5-7 M⍀ when filled with the intrapipette solution. For recording interneurons the intrapipette solution contained the following (in mM): K-gluconate 130, KCl 5, MgCl 2 2, creatine phosphate 10, HEPES 10, Na 2 ATP 2, Na 2 GTP 1, and biocytin, 7. The solution also contained 100 M Fluo-5F (Invitrogen, K D ϳ 2.3 M). The pH was adjusted to 7.3, the osmolarity was 290 -300 mOsm. Interneurons were held between Ϫ60 and Ϫ65 mV (with 0 to Ϫ250 pA DC current injections) and pairs of action potentials (APs) at 10 Hz were evoked in every 30 s with 1.5-2 ms long depolarizing (1-1.2 nA) current pulses. Presynaptic interneurons were selected based on their DsRed content. The interneurons were sampled from strata pyramidale, lucidum, and radiatum. The physiological characteristics of interneurons were determined from their voltage responses to series of hyper-and depolarizing square current pulses of 800 ms duration and amplitudes ranging from Ϫ100 to 100 pA with 10 pA increments and to 500 pA with 50 pA increments. Intrapipette solution used for the postsynaptic cell contained (in mM) 80 CsCl, 60 Cs-gluconate, 1 MgCl 2 , 2 Mg-ATP, 3 NaCl, 10 HEPES, 5 QX-314 [2(triethylamino)-N-(2,6-dimethylphenyl) acetamine] and 25 M AlexaFluor 488, adjusted to pH 7.3 with CsOH. The osmolarity of the solution was 295 mOsm. Unitary IPSCs (uIPSCs) were recorded in monosynaptically connected pyramidal cells that were voltage-clamped at the holding potential of Ϫ65 mV. Series resistance was frequently monitored and 65% compensation was applied. In paired recordings, similarly to the imaging experiments, we waited 1 h to equilibrate the intrapipette solution within the cells. During this period, we obtained a stable recording in a connected pyramidal cell. After 1 h, 40 uIPSCs were recorded as a control period within 20 min, followed by the drug application. Drugs were applied for 35 or 50 min and the values obtained during the last 20 min were used to compare with the values recorded in control conditions. In addition, we performed control experiments in which either BSA or aCSF was applied without any drug to reveal the magnitude of the "rundown" during our experimental conditions. These control experiments were randomly distributed throughout the whole experiment series and showed similar amplitude distribution and similar extent of change in series resistance. Control experiments using DMSO were performed in one block. On average, we found a rundown of 17.9 Ϯ 13.2% (n ϭ 8) in control experiments for -Conotoxin GVIA (-CTx) treatment, 15.3 Ϯ 35% (n ϭ 4) in controls for AM251 application, and 8.3 Ϯ 3.6% (n ϭ 8) in controls for carbachol (CCh) treatment, which was used to correct the effects of drugs. DMSO applied at 0.01% caused a nonsignificant change in the IPSC amplitude (11.4 Ϯ 11.2%, n ϭ 4; p ϭ 0.26, paired t test). In addition, all experiments that showed Ͼ50% rundown during the control period (i.e., in the first 20 min) were discarded.
Two-photon imaging. For imaging experiments, the same stimulus and experimental protocol was applied as in the electrophysiological recordings. Recording solutions were also identical, except that intrapipette solution for imaging experiments contained 25 M AlexaFluor 594 (Invitrogen). Cells were visualized in slices using a Femto2D microscope (Femtonics) equipped with oblique infrared illumination and a waterimmersion lens (25ϫ, 1.05 NA, Olympus). Whole-cell recordings from cholecystokinin (CCK)-immunopositive interneurons were performed in current-clamp mode using a MultiClamp 700A amplifier. Electrophysiological traces were filtered at 3 kHz and digitized on-line at 20 kHz. Drugs were applied using a recirculation system with a peristaltic pump, where the total volume was ϳ6 ml and the solutions were equilibrated with 95% O 2 and 5% CO 2 . Two-photon imaging experiments were performed with a Femto2D laser-scanning microscope, using a MaiTai femtosecond pulsing laser (SpectraPhysics) tuned to 810 nm. A detailed description of the setup and calculation of G/G max values was described previously (Holderith et al., 2012) . Bouton-strings at 20 -60 m depth in the tissue and usually between 150 and 300 m from the soma were selected preferentially at or near the stratum pyramidale in the CA3 region. There was no correlation between the distance of the boutonstring from the soma and (1) (3) amplitude and SD of the AlexaFluor 594 fluorescent signal. After 1 h loading period, a 20 min "control" scanning period was performed during which ϳ10 -15 boutons were scanned each two times separated by 30 s. The same 20 min scanning period was repeated on the same boutons after a 15 (for AM251, CCh, or 1 M -Conotoxin GVIA; -CTx) or a 30 (for 1-50 nM -CTx) min drug equilibration period. Transients derived from the two sequential scans were averaged for each bouton. The recorded [Ca 2ϩ ] i transients were considered to originate from boutons, if the [Ca 2ϩ ] i transient following filtering at 50 Hz reached the peak within 18 ms after the action potential, and the signal increased monotonically. If they passed this test, the peak of [Ca 2ϩ ] i transients was determined with 200 Hz filtering and the largest value within a time window of 2-8 ms after the action potential was used. The amplitude of [Ca 2ϩ ] i transients went through a gradual decline during the ϳ1 h of imaging session in aCSF, therefore all drug effects were normalized to their corresponding reduction obtained in aCSF. These reductions controlling 1 M -CTx, 1-50 nM -CTx, 1-2 M AM251, and CCh, were 18.4 Ϯ 4.7%, 16.3 Ϯ 4.4%, 10.5 Ϯ 14.1%, and 10.5 Ϯ 14.1%, respectively. All data are normalized with these values except raw traces. Control experiments were performed to show that 1 mg/ml BSA together with 0.1% DMSO has no effect on the amplitude of the [ Immunohistochemistry. After recordings, slices were fixed in a fixative containing 4% paraformaldehyde, 0.2% picric acid in 0.1 M phosphate buffer (PB; pH 7.4) at 4°C at least for 12 h. Following the fixation, the slices were washed in PB several times, embedded in agarose (2%) and resectioned at 50 -80 m thickness. Sections were washed with PB and blocked in normal goat serum (10%), made up in Tris-buffered saline (TBS; pH ϭ 7.4). CB 1 was visualized using a rabbit or a guinea pig anti-CB 1 antibody (1:1000; Cayman Chemicals and Frontier Institute, respectively) diluted in TBS containing 0.1% Triton X-100. Following several washes in TBS, AlexaFluor 488-conjugated goat anti-rabbit IgG (1:500; Jackson ImmunoResearch) or Dylight405-conjugated goat antiguinea pig (1:500, Jackson ImmunoResearch) was used to visualize the CB 1 immunoreaction, while Cy3-conjugated streptavidin (1:500 -1:3000; Invitrogen) was used to visualize the biocytin. Sections were then mounted on slides in Vectashield (Vector Laboratories). Images were acquired using Olympus FV1000 confocal microscope with either a 20ϫ or a 60ϫ oilimmersion objective or with an AxioImager.Z1 using 40ϫ objective (Zeiss). Cells identified as basket or mossy fiber-associated interneurons based on their axonal arborizations were included in the analysis (Gulyás et al., 1993; Losonczy et al., 2004) . Only CB 1 -immunopositive interneurons were included in the study. Subsequently, some cells were further developed by immunoperoxidase reaction (ABC; Vector Laboratories) using 3-3-diaminobenzidine tetrahydrochloride together with ammonium nickel sulfate hexahydrate ((NH 4 ) 2 (NiSO 4 ) 2* 6H 2 O) (DAB-Ni) as a chromogen. After dehydration and embedding in Durcupan, representative cells were reconstructed with the aid of a drawing tube using a 40ϫ objective.
Drugs. -CTx (Tocris Bioscience, product no. 1085) stock was dissolved in distilled water and diluted to a final concentration in aCSF together with 1 mg/ml BSA. AM251 (Tocris Bioscience, product no. 1117) was dissolved in DMSO to reach 10 mM stock solution, CCh (20 mM stock) was dissolved in distilled water. All drugs were purchased from Sigma-Aldrich unless indicated otherwise.
Data analysis and statistical tests. Two-photon imaging data and partly the electrophysiological data were analyzed using MES (Femtonics). Data were plotted using Origin 8.6 software. Statistical significance of the drug effect was assessed with Student's paired t test for experiments using -CTx and Wilcoxon signed rank test for experiments applying AM251 or CCh. Results were considered significant at p Ͻ 0.05. Data are presented as mean Ϯ SD unless indicated otherwise.
Calculation of the [Ca 2ϩ
] i -uIPSC relationship curve. First, dose-response curves for -CTx were determined on [Ca 2ϩ ] i transients and uIPSCs. The tested drug concentrations were 0.1, 1, 10, and 50 nM for uIPSCs, and 1, 10, 50, and 1000 nM for [Ca 2ϩ ] i transients. Throughout these experiments, 1 M AM251 was applied to avoid differential tonic CB1 activation. By fitting the dose-response curves with a sigmoidal function (f(x) ϭ 1/(1 ϩ (x/x 0 ) p )), the effect of 1 M -CTx on uIPSCs and 0.1 nM -CTx on [Ca 2ϩ ] i transients could be estimated. Incorporating these two values into the measured dataset, a [Ca 2ϩ ] i -uIPSC relationship curve was constructed (see Fig. 2M ). Each point corresponds to a given -CTx concentration (from left to right: 1000, 50, 10, 1, and 0.1 nM). Red data point shows the effect of tonic CB 1 activity that is the inverse of the AM251 effect. In other words, it corresponds to uIPSCs amplitude and peak [Ca 2ϩ ] i transients in control condition, from which AM251 application enhanced the amplitudes to the 1:1 data point. We calculated this point by taking the effects of AM251 in individual cells, took their reciprocal values and calculated the average and SEM. Blue symbol represents the effect of CCh normalized to control condition (to the red point).
The relationship between [Ca 2ϩ ] i and uIPSC was estimated by fitting it with a power function (f(x) ϭ x m ) using dataset from -CTx experiments. Fitting the recorded data gave an exponent m ϭ 2.2. We performed bootstrap analysis to validate that our experimental dataset size was large enough for correct estimation of the fit, and calculate confidence intervals. Bootstrap analysis resulted in an m value of 2.2 Ϯ 0.4. Data points regarding CCh and AM251 application (see Fig. 2M , blue and red symbols) fell inside the confidence intervals, therefore CCh and AM251 effect were considered not significantly different from Ca 2ϩ channel blocking effect of -CTx.
Results
Here, we aimed to uncover how CB 1 activation leads to the suppression of GABAergic transmission in the hippocampus. As a first step, we determined the relationship between action potential-evoked [Ca 2ϩ ] transients in axon terminals ([Ca 2ϩ ] i ) of CCK and CB 1 -expressing perisomatic targeting interneurons (basket and mossy fiber-associated cells) and the amplitude of uIPSCs (Bucurenciu et al., 2010) recorded in CA3 pyramidal cells (PCs). To eliminate the possible effects of differential tonic CB 1 activation in slices, a CB 1 antagonist (AM251, 1 M) was continuously applied. Bath application of -CTx (a Cav2.2/N-type calcium channel inhibitor) at different concentrations decreased the uIPSC amplitudes (Wilson et al., 2001 ) in a dose-dependent manner and fully blocked the postsynaptic response at concentrations Ͼ50 nM (Fig. 1A-D) . In a separate set of experiments, -CTx dose-dependently reduced [Ca 2ϩ ] i transients evoked by single action potentials (Fig. 1E) . Importantly, 1 M -CTx completely eliminated the [Ca 2ϩ ] i transients, demonstrating that action potential-evoked Ca 2ϩ entry into CB 1 -immunopositive boutons is mainly, if not exclusively conducted via N-type Ca 2ϩ channels.
To reveal the relationship between Ca 2ϩ entry and subsequent transmitter release, we plotted the normalized uIPSC amplitudes as a function of normalized peak [Ca 2ϩ ] i obtained in paired recordings and presynaptic Ca 2ϩ imaging, respectively (Fig. 2) . The plot was fitted with a power function with an exponent of 2.2 (Fig. 2M ) , showing that a supralinear cooperativity of Ca 2ϩ controls the GABA release from CCKϩ axon terminals. Next, we sought to reveal the mechanisms underlying the suppression of inhibitory synaptic transmission by CB 1 . If CB 1 activation reduces IPSC amplitude solely via the inhibition of Ca 2ϩ entry, altering CB 1 function should result in changes in the corresponding [Ca 2ϩ ] i and uIPSC values in a way that they ought to fall onto the [Ca 2ϩ ] i -uIPSC curve derived from the -CTx experiments. Alternatively, if these changes do not follow the [Ca 2ϩ ] i -uIPSC relationship, additional mechanisms must play a role. To address this issue, first we examined the effect of tonic CB 1 activation on uIPSCs. AM251 (1-2 M) application increased the peak amplitude of uIPSCs in individual pairs to dif- ferent extents (Fig. 2 A, C) , suggesting that there is a differential tonic activation of the CB 1 at these inhibitory synapses. Next, the synthesis of endocannabinoids was augmented by bath application of an acetylcholine receptor agonist (CCh; 5 M; Kim et al., 2002; Makara et al., 2007) . The drug treatment resulted in a significant reduction in the peak amplitude of the uIPSCs (Fig.  2 B, D) , an effect that has been shown to be mediated via CB 1 in the CA3 region (Szabó et al., 2010) . In parallel experiments, action potential-evoked [Ca 2ϩ ] i transients were augmented by AM251 and suppressed by CCh (Fig. 2E-J ) . Both AM251 and CCh caused a more robust change in the uIPSC amplitudes than in [Ca 2ϩ ] i (Fig. 2 K, L 
Discussion
We have examined the cellular mechanisms underlying the suppression of inhibitory synaptic transmission upon CB 1 activation in the CA3 region of acute hippocampal slices. Our principal findings are as follows: (1) (Llano et al., 2000) , its magnitude may be low at stimulus frequencies used in the present study (Carter et al., 2002) . In addition, spontaneous opening of N-type Ca 2ϩ channels at CB 1 -expressing axon terminals can contribute also to the action potential-independent GABA release (Goswami et al., 2012) , which could play a role in stabilizing synaptic function (Farrant and Nusser, 2005) .
Similar to other central synapses (von Gersdorff et al., 1998; Fedchyshyn and Wang, 2005; Bucurenciu et al., 2010) , at CCKexpressing inhibitory perisomatic synapses the cooperativity of Ca 2ϩ is supralinear, even though the GABA release is not as tightly coupled to the opening of presynaptic Ca 2ϩ channels as in parvalbumin-containing GABAergic axon terminals (Hefft and Jonas, 2005; Bucurenciu et al., 2008) . The obtained power coefficient of 2.2 is somewhat greater than those determined for the relationship between the presynaptic [Ca 2ϩ ] and the magnitude of postsynaptic responses at parvalbumin-expressing inhibitory synapses in the dentate gyrus (1.6) or at both auditory hair cell and retinal ribbon synapses (1.1-1.4), but lower than that determined at young calyx of Held synapses (Ͼ3; Eggermann et al., 2012) . Because N-type Ca 2ϩ channels are activated with high efficacy by action potentials (Li et al., 2007) , only a relatively small number of channels located near the active zone should be responsible for presynaptic Ca 2ϩ influx evoking GABA release at CCK/CB1-expressing synapses (Eggermann et al., 2012) .
We clarified that inhibition of N-type Ca 2ϩ channel function is the main, if not the sole mechanism underlying the CB 1 -mediated suppression of synaptic inhibition, which is in line with a previous proposal based on data obtained in cell lines (Mackie and Hille, 1992) . By uncovering the detailed mechanisms of how presynaptically located CB 1 regulates transmitter release, we open up new avenues leading to a better understanding how endocannabinoids and 9d THC exert their influence on the CNS.
